These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Endothelin-A receptor antagonist-mediated vasodilatation is attenuated by inhibition of nitric oxide synthesis and by endothelin-B receptor blockade. Verhaar MC; Strachan FE; Newby DE; Cruden NL; Koomans HA; Rabelink TJ; Webb DJ Circulation; 1998 Mar; 97(8):752-6. PubMed ID: 9498538 [TBL] [Abstract][Full Text] [Related]
6. Interactions between nitric oxide and endothelin in the regulation of vascular tone of human resistance vessels in vivo. Cardillo C; Kilcoyne CM; Cannon RO; Panza JA Hypertension; 2000 Jun; 35(6):1237-41. PubMed ID: 10856270 [TBL] [Abstract][Full Text] [Related]
7. Altered peripheral vascular responses to exogenous and endogenous endothelin-1 in patients with well-compensated cirrhosis. Helmy A; Jalan R; Newby DE; Johnston NR; Hayes PC; Webb DJ Hepatology; 2001 Apr; 33(4):826-31. PubMed ID: 11283846 [TBL] [Abstract][Full Text] [Related]
8. Endothelin-1 vasoconstriction and the age-related decline in endothelium-dependent vasodilatation in men. Westby CM; Weil BR; Greiner JJ; Stauffer BL; DeSouza CA Clin Sci (Lond); 2011 Jun; 120(11):485-91. PubMed ID: 21143196 [TBL] [Abstract][Full Text] [Related]
9. Selective endothelin ETA and dual ET(A)/ET(B) receptor blockade improve endothelium-dependent vasodilatation in patients with type 2 diabetes and coronary artery disease. Rafnsson A; Shemyakin A; Pernow J Life Sci; 2014 Nov; 118(2):435-9. PubMed ID: 24607773 [TBL] [Abstract][Full Text] [Related]
10. Enhanced vasodilatation to endothelin antagonism in patients with compensated cirrhosis and the role of nitric oxide. Helmy A; Newby DE; Jalan R; Hayes PC; Webb DJ Gut; 2003 Mar; 52(3):410-5. PubMed ID: 12584225 [TBL] [Abstract][Full Text] [Related]
11. Improved endothelium-dependent vasodilation after blockade of endothelin receptors in patients with essential hypertension. Cardillo C; Campia U; Kilcoyne CM; Bryant MB; Panza JA Circulation; 2002 Jan; 105(4):452-6. PubMed ID: 11815427 [TBL] [Abstract][Full Text] [Related]
12. A causal role for endothelin-1 in the vascular adaptation to skeletal muscle deconditioning in spinal cord injury. Thijssen DH; Ellenkamp R; Kooijman M; Pickkers P; Rongen GA; Hopman MT; Smits P Arterioscler Thromb Vasc Biol; 2007 Feb; 27(2):325-31. PubMed ID: 17122448 [TBL] [Abstract][Full Text] [Related]
13. Endothelin-1 and vascular tone in subjects with atherogenic risk factors. Nohria A; Garrett L; Johnson W; Kinlay S; Ganz P; Creager MA Hypertension; 2003 Jul; 42(1):43-8. PubMed ID: 12756218 [TBL] [Abstract][Full Text] [Related]
14. Action of the endothelin receptor (ETA) antagonist BQ-123 on forearm blood flow in young normotensive subjects. Wimalasundera RC; McG Thom SA; Regan L; Hughes AD Clin Sci (Lond); 2002 Jun; 102(6):661-6. PubMed ID: 12049621 [TBL] [Abstract][Full Text] [Related]
15. Endothelin B receptor contribution to peripheral microvascular function in women with polycystic ovary syndrome. Wenner MM; Taylor HS; Stachenfeld NS J Physiol; 2011 Oct; 589(Pt 19):4671-9. PubMed ID: 21825025 [TBL] [Abstract][Full Text] [Related]
16. Endogenous endothelin in human coronary vascular function: differential contribution of endothelin receptor types A and B. Halcox JP; Nour KR; Zalos G; Quyyumi AA Hypertension; 2007 May; 49(5):1134-41. PubMed ID: 17353514 [TBL] [Abstract][Full Text] [Related]
17. Ethnic differences in the vasoconstrictor activity of endogenous endothelin-1 in hypertensive patients. Campia U; Cardillo C; Panza JA Circulation; 2004 Jun; 109(25):3191-5. PubMed ID: 15148269 [TBL] [Abstract][Full Text] [Related]
18. Vasodilator effects of endothelin-converting enzyme inhibition and endothelin ETA receptor blockade in chronic heart failure patients treated with ACE inhibitors. Love MP; Haynes WG; Gray GA; Webb DJ; McMurray JJ Circulation; 1996 Nov; 94(9):2131-7. PubMed ID: 8901663 [TBL] [Abstract][Full Text] [Related]
19. Vasoconstriction to endogenous endothelin-1 is impaired in patients with type II diabetes mellitus. McAuley DF; Nugent AG; McGurk C; Maguire S; Hayes JR; Johnston GD Clin Sci (Lond); 2000 Sep; 99(3):175-9. PubMed ID: 11787468 [TBL] [Abstract][Full Text] [Related]
20. Role of endothelin in the increased vascular tone of patients with essential hypertension. Cardillo C; Kilcoyne CM; Waclawiw M; Cannon RO; Panza JA Hypertension; 1999 Feb; 33(2):753-8. PubMed ID: 10024340 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]